Theraflu Expressmax Daytime Severe Cold and Cough and Theraflu Expressmax Nighttime Severe Cold and Cough (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the Theraflu Expressmax Daytime Severe Cold and Cough and Theraflu Expressmax Nighttime Severe Cold and Cough drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
NON-PROPRIETARY NAME: | acetaminophen, dextromethorphan HBr, phenylephrine HCl, diphenhydramine HCl |
SUBSTANCE NAME: | |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2016-07-05 |
END MARKETING DATE: | 0000-00-00 |
Theraflu Expressmax Daytime Severe Cold and Cough and Theraflu Expressmax Nighttime Severe Cold and Cough HUMAN OTC DRUG Details:
Item Description | Theraflu Expressmax Daytime Severe Cold and Cough and Theraflu Expressmax Nighttime Severe Cold and Cough from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2016-07-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0067-8138_44fca1d9-5222-47c2-ab52-c9f695eb8e9b |
PRODUCT NDC: | 0067-8138 |
APPLICATION NUMBER: | part341 |